belantamab mafodotin
gsk
['mmsm', 'multiple myeloma', 'belantamab', 'dreamm']
final dreamm-2 analysis confirms durability of belantamab mafotodin monotherapy in relapsed/refractory multiple myeloma #mmsm #ash22 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.